Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human Endogenous Retrovirus K envelope protein (HERV-K ENV) is a glycoprotein encoded by the env gene of the HERV-K family. It mediates receptor recognition and membrane fusion, and its aberrant expression is associated with various cancers and neurodegenerative diseases. It is being explored as an immunotherapy target in melanoma.
CAR-T therapies target melanoma cells expressing HERV-K ENV
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Endogenous Retrovirus K Envelope Protein (HERV-K ENV).